AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vyome Holdings, Inc Director's Dealing 2017

Jan 17, 2017

33955_dirs_2017-01-17_587a6262-4c3a-4077-b966-c445c70cf2c9.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OBALON THERAPEUTICS INC (OBLN)
CIK: 0001427570
Period of Report: 2017-01-12

Reporting Person: SHACKNAI JONAH (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially held	0	Direct